Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis

Atherosclerosis affects millions of people worldwide. However, the wide variety of limitations in the current therapeutic options leaves much to be desired in future lipid-lowering therapies. For example, although statins, which are the first-line treatment for coronary heart disease (CHD), reduce t...

Full description

Bibliographic Details
Main Authors: Eftaxia-Konstantina Valanti, Katerina Dalakoura-Karagkouni, Despina Sanoudou
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:http://www.mdpi.com/2075-4426/8/4/34